ZIOPHARM (ZIOP) Looking to Partner for Cancer Drug Development
Tweet
Share
E-mailGet Alerts ZIOP Hot Sheet
Join SI Premium – FREE
ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) CEO Jonathan Lewis said the pharma is in talks for a partnership over its cancer drug. He also said the company's drug for soft-tissue sarcoma is in late-stage testing.
Comments were made during an interview with Bloomberg.
Comments were made during an interview with Bloomberg.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA approves Novartis Pluvicto for earlier-stage prostate cancer
- Terra Rossa Gold starts drilling at Colombia gold project
- Curis doses first five patients in CLL study, eyes December data
Create E-mail Alert Related Categories
FDA, Insiders' Blog, Management CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
